"Checkpoint Therapeutics Price Target Announced at $4.80/Share by D. Boral Capital" published at 8:22 a.m. ET misstated that the price target was announced at $4.80/share. The price target was cut to $4.80/share From $9.00/share.
(END) Dow Jones Newswires
March 10, 2025 11:44 ET (15:44 GMT)